aldosterone has been researched along with transforming growth factor beta in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (7.94) | 18.2507 |
2000's | 41 (65.08) | 29.6817 |
2010's | 15 (23.81) | 24.3611 |
2020's | 2 (3.17) | 2.80 |
Authors | Studies |
---|---|
Franco-Saenz, R; Gentry, LE; Gupta, P; Mulrow, PJ | 1 |
Husted, RF; Matsushita, K; Stokes, JB | 1 |
Franco-Saenz, R; Gupta, P; Mulrow, PJ | 1 |
Husted, RF; Stokes, JB | 1 |
Chambaz, EM; Defaye, G; Feige, JJ; Galtier, A; Keramidas, M; Liakos, P | 1 |
Husted, RF; Sigmund, RD; Stokes, JB | 1 |
Stokes, JB | 1 |
Ramires, FJ; Sun, Y; Zhang, J; Zhang, JQ | 1 |
Chai, Q; Hermans, C; Krag, S; Nielsen, CB; Osterby, R; Wogensen, L | 1 |
Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Haller, H; Luft, FC; Müller, DN; Park, JK; Schmidt, F; Shagdarsuren, E | 1 |
Berrou, J; Hertig, A; Rerolle, JP; Rondeau, E; Vigneau, C | 1 |
Kangawa, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nishikimi, T; Ono, H | 1 |
Border, WA; Gaedeke, J; Noble, NA | 1 |
Bobadilla, NA; Feria, I; Gamba, G; García-Torres, R; González, MA; Juárez, P; López-Casillas, F; Pichardo, I; Ramírez, V; Uribe, N | 1 |
Bernhardt, R; Defaye, G; Feige, JJ; Lenz, D; Liakos, P | 1 |
Bloem, LJ; Chun, TY; Pratt, JH | 1 |
Kessler, E; Kessler-Icekson, G; Levy, MJ; Schlesinger, H; Shalitin, N | 1 |
Barty, MM; Carlesso, G; Davidson, JM; Fogo, AB; Gaspert, A; Ma, LJ; Sheppard, D; Yang, H | 1 |
de Boer, RA; de Borst, MH; Huitema, S; Navis, G; van Gilst, WH; van Goor, H; Vis, LM | 1 |
Hostetter, TH; Juknevicius, I; Kren, S; Lee, R; Segal, Y | 1 |
Aizawa, T; Ishizaka, N; Iso-o, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M | 1 |
González-Núñez, D; Natarajan, R; Poch, E; Solé, M | 1 |
Kurabayashi, M | 1 |
Chun, TY; Pratt, JH | 1 |
Cockwell, P; Eardley, KS; Hewison, M; Howie, AJ; Hughes, SV; Lepenies, J; Quinkler, M; Stewart, PM; Zehnder, D | 1 |
Chen, YP; Luo, Y | 1 |
Kobayashi, N; Matsuoka, H; Nakano, S; Ohno, T; Yoshida, K | 1 |
Abe, Y; Baba, R; Fan, YY; Fujita, M; Hosomi, N; Kimura, S; Kohno, M; Miyatake, A; Nagai, Y; Nishiyama, A; Sun, GP | 1 |
Asano, Y; Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Minamino, T; Okada, K; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H; Tsukamoto, O; Yamasaki, S; Yulin, L | 1 |
Abe, Y; Fan, YY; Guo, P; Kimura, S; Kiyomoto, H; Kohno, M; Li, DT; Miyata, K; Nagai, Y; Nishiyama, A; Ohmori, K; Sun, GP | 1 |
Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M | 1 |
Chen, J; Gu, Y; Hao, CM; Lai, L; Lin, S | 1 |
Kitamura, K; Tomita, K | 1 |
Akdag, I; Filiz, G; Gullulu, M; Kahvecioglu, S; Savci, V | 1 |
Adachi, M; Ha, V; Kitamura, K; Ko, T; Maekawa, A; Miyoshi, T; Nonoguchi, H; Shiraishi, N; Tomita, K; Tuyen, DG; Wakida, N | 1 |
Demer, LL; Jaffe, IZ; Mendelsohn, ME; Newfell, BG; Tintut, Y | 1 |
Inagaki, K; Makino, H; Miyoshi, T; Mukai, T; Ogura, T; Otani, H; Otsuka, F; Suzuki, J; Takeda, M | 1 |
Fujita, T; Goto, A; Kobayashi, N; Matsuoka, H; Onozato, ML; Tojo, A | 1 |
Adrogue, HJ; Huang, XR; Lan, HY; Soltero, L; Wang, W; Zhang, P | 1 |
Chatziantoniou, C; Dussaule, JC | 1 |
Siragy, HM; Xue, C | 1 |
Chander, PN; Chun, TY; Kim, JW; Pratt, JH; Stier, CT | 1 |
Carvajal, CA; Castillo, CR; Contreras, FJ; Fardella, CE; Herrada, AA; Kalergis, AM; Mosso, LM; Stehr, CB | 1 |
Armanini, D; Calò, LA; Davis, PA; Mormino, P; Pagnin, E; Pessina, AC; Rossi, GP | 1 |
Du, J; Fan, YY; Fu, H; Fujisawa, Y; Hitomi, H; Hosomi, N; Kimura, S; Kiyomoto, H; Kohno, M; Lu, XM; Nagai, Y; Nakano, D; Nishiyama, A; Ohmori, K | 1 |
Beineke, A; Hosten, N; Maschke, U; Mullins, JJ; Peters, BS; Peters, J; Rettig, R; Riegel, T; Schlüter, T | 1 |
Hayashi, T; Kimura, S; Kitada, K; Kitaura, Y; Kobayashi, K; Kurumazuka, D; Matsuda, H; Matsumoto, C; Matsumura, Y; Mori, T; Shirakawa, H | 1 |
Díez, J; González, A; López, B | 1 |
Casarini, DE; Coelho, MS; Ferreira, DN; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Rosa, KT | 1 |
Fujita, H; Harasawa, S; Hirayama, A; Koike, M; Kushiro, T; Nagao, K; Okubo, K; Otsuka, Y | 1 |
Blessing, M; Gekle, M; Grossmann, C; Hauptmann, S; Neumann, J; Rabe, S; Ruhs, S; Schneider, B; Schreier, B | 1 |
Chan, LY; Chow, CW; Lai, KN; Lam, MF; Leung, JC; Lim, AI; Tang, SC | 1 |
Bollag, WB; Nishimoto, K; Rainey, WE; Seki, T | 1 |
Chang, JW; Kim, JH; Kim, JS; Kim, SB; Lee, JH; Lee, SK; Park, JS | 1 |
Day, EC; Shlipak, MG | 1 |
Dai, Z; He, H; Huang, C; Meng, Y; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q | 1 |
Geier, A; Happ, K; Jahn, D; Link, S; Queisser, N; Schupp, N; Zimnol, A | 1 |
Azizan, EA; Brighton, CA; Brown, MJ; Figg, N; Maniero, C; McFarlane, I; Neogi, SG; Shaikh, LH; Teo, AE; Zhao, W; Zhou, J | 1 |
Albertini, R; Avanzini, MA; Bedino, G; Corradetti, V; Dal Canton, A; Esposito, P; Gregorini, M; Ingo, D; Libetta, C; Mantelli, M; Milanesi, S; Pattonieri, EF; Peressini, S; Rampino, T; Rocca, C; Serpieri, N; Valsania, T | 1 |
Donderski, R; Grajewska, M; Manitius, J; Miśkowiec, I; Odrowąż-Sypniewska, G; Siódmiak, J; Stefańska, A; Stróżecki, P; Sulikowska, B | 1 |
Gong, H; Li, H; Lu, Y; Ma, X; Wang, B; Wang, C; Wu, Z; Yan, Y; Zhang, X | 1 |
Aljohmani, AI; Alzoubi, KH; Mayyas, FA | 1 |
Armani, A; Caprio, M; Cecconi, F; De Zio, D; Filippini, A; Giampietri, C; Mammi, C; Mandatori, S; Marzolla, V; Pacella, I; Padula, F; Piconese, S; Savoia, C; Starace, D; Taurino, M; Vitiello, L | 1 |
8 review(s) available for aldosterone and transforming growth factor beta
Article | Year |
---|---|
Physiologic resistance to the action of aldosterone.
Topics: Aldosterone; Animals; Drug Resistance; Hormones; Kidney Medulla; Kidney Tubules, Collecting; Transforming Growth Factor beta | 2000 |
[Plasminogen activator inhibitor type 1: physiology and role in renal physiopathology].
Topics: Aldosterone; Fibrinolysis; Fibrosis; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Transforming Growth Factor beta | 2001 |
Angiotensin II and progressive renal insufficiency.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Endothelins; Humans; Kidney Failure, Chronic; Plasminogen Activator Inhibitor 1; Receptors, Angiotensin; Transforming Growth Factor beta | 2002 |
[PPARs and fibrosis].
Topics: Adipocytes; Aldosterone; Animals; Connective Tissue Growth Factor; Fibrosis; Immediate-Early Proteins; Inflammation; Intercellular Signaling Peptides and Proteins; Mice; NADPH Oxidases; Peroxisome Proliferator-Activated Receptors; Transforming Growth Factor beta | 2005 |
[Prostasin].
Topics: Aldosterone; Amyloid beta-Protein Precursor; Animals; Benzamidines; Epithelial Sodium Channels; Guanidines; Humans; Hypertension; Immediate-Early Proteins; Membrane Glycoproteins; Protease Nexins; Protein Serine-Threonine Kinases; Receptors, Cell Surface; Serine Endopeptidases; Serine Proteinase Inhibitors; Sodium Channels; Transforming Growth Factor beta; Trypsin Inhibitor, Kunitz Soybean | 2006 |
Is kidney injury a reversible process?
Topics: Aldosterone; Animals; Extracellular Matrix; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Receptors, Cell Surface; Transforming Growth Factor beta | 2008 |
Lessons from the gene expression pattern of the rat zona glomerulosa.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Calcium; Cardiovascular Diseases; Gene Expression; Potassium; Rats; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta; Wnt Proteins; Zona Fasciculata; Zona Glomerulosa | 2013 |
Biomarkers for incident CKD: a new framework for interpreting the literature.
Topics: Acute-Phase Proteins; Aldosterone; Biomarkers; Connective Tissue Growth Factor; Creatinine; Cystatin C; Genetic Markers; Genetic Predisposition to Disease; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Homocysteine; Humans; Lipocalin-2; Lipocalins; Membrane Glycoproteins; Peptides; Proto-Oncogene Proteins; Receptors, Virus; Renal Insufficiency, Chronic; Risk Factors; Transforming Growth Factor beta; Trefoil Factor-3; Uromodulin | 2013 |
1 trial(s) available for aldosterone and transforming growth factor beta
Article | Year |
---|---|
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta | 2006 |
54 other study(ies) available for aldosterone and transforming growth factor beta
Article | Year |
---|---|
Transforming growth factor-beta 1 inhibits aldosterone and stimulates adrenal renin in cultured bovine zona glomerulosa cells.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Bucladesine; Cattle; Cells, Cultured; Cyclic AMP; Enzyme Precursors; Mineralocorticoid Receptor Antagonists; Renin; Transforming Growth Factor beta; Zona Glomerulosa | 1992 |
Induction of resistance to mineralocorticoid hormone in cultured inner medullary collecting duct cells by TGF-beta 1.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aldosterone; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Biological Transport; Cells, Cultured; DNA; Drug Resistance; Endothelins; Epidermal Growth Factor; Female; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Insulin-Like Growth Factor I; Kidney Medulla; Kidney Tubules, Collecting; Kinetics; Nerve Growth Factors; Platelet-Derived Growth Factor; Radioisotope Dilution Technique; Rats; Rats, Wistar; Sodium; Sodium Radioisotopes; Time Factors; Transforming Growth Factor beta | 1994 |
Transforming growth factor-beta 1 inhibits aldosterone biosynthesis in cultured bovine zona glomerulosa cells.
Topics: Aldosterone; Angiotensin II; Animals; Cattle; Cell Survival; Cells, Cultured; Corticosterone; Desoxycorticosterone; Kinetics; Mineralocorticoid Receptor Antagonists; Potassium; Pregnenolone; Transforming Growth Factor beta; Zona Glomerulosa | 1993 |
Separate regulation of Na+ and anion transport by IMCD: location, aldosterone, hypertonicity, TGF-beta 1, and cAMP.
Topics: Absorption; Aldosterone; Animals; Anions; Biological Transport; Cells, Cultured; Chlorides; Cyclic AMP; Female; Hypertonic Solutions; Kidney Medulla; Kidney Tubules, Collecting; Rats; Rats, Wistar; Sodium; Tissue Distribution; Transforming Growth Factor beta | 1996 |
ACTH angiotensin II and TGF beta participate in the regulation of steroidogenesis in bovine adrenal glomerulosa cells.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Cattle; Cell Differentiation; Cells, Cultured; Cytochrome P-450 CYP11B2; Hydrocortisone; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Transforming Growth Factor beta; Zona Glomerulosa | 1996 |
Mechanisms of inactivation of the action of aldosterone on collecting duct by TGF-beta.
Topics: Aldosterone; Amiloride; Animals; Cells, Cultured; Drug Interactions; Epithelial Sodium Channels; Glucocorticoids; Kidney Tubules, Collecting; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Rats; Rats, Wistar; RNA, Messenger; Sodium; Sodium Channels; Sodium-Potassium-Exchanging ATPase; Transforming Growth Factor beta | 2000 |
Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats.
Topics: Aldosterone; Angiotensin II; Animals; Kidney Diseases; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Transforming Growth Factor beta | 2000 |
TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man.
Topics: Aldosterone; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Circadian Rhythm; Disease Models, Animal; Diuresis; Female; Glomerular Filtration Rate; Humans; Juxtaglomerular Apparatus; Kidney Failure, Chronic; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Promoter Regions, Genetic; Reference Values; Swine; Transforming Growth Factor beta | 2000 |
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiovascular Diseases; Fibroblast Growth Factor 2; Heart; Immunohistochemistry; Mineralocorticoid Receptor Antagonists; NF-kappa B; Organ Size; Platelet-Derived Growth Factor; Rats; Receptors, Mineralocorticoid; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Transforming Growth Factor beta; Valine; Valsartan | 2001 |
Long-term adrenomedullin infusion improves survival in malignant hypertensive rats.
Topics: Adrenomedullin; Aldosterone; Angiotensin II; Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Heart Rate; Humans; Hypertension, Malignant; Infusion Pumps; Injections, Subcutaneous; Kidney; Male; Organ Size; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Vasodilator Agents | 2002 |
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.
Topics: Aldosterone; Animals; Chronic Disease; Collagen Type I; Collagen Type IV; Cyclosporine; Fibronectins; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Transforming growth factor beta1 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Analysis of Variance; Androstenedione; Angiotensin II; Colforsin; Corticosterone; Cortodoxone; Cytochrome P-450 CYP11B2; Depression, Chemical; Humans; Hydrocortisone; RNA, Messenger; Steroid 11-beta-Hydroxylase; Transforming Growth Factor beta; Tumor Cells, Cultured | 2003 |
Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes.
Topics: Aldosterone; Animals; Animals, Newborn; Cells, Cultured; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucocorticoids; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for co-regulation with type I collagen.
Topics: Aldosterone; Animals; Antioxidants; Ascorbic Acid; Blotting, Northern; Blotting, Western; Bone Morphogenetic Protein 1; Bone Morphogenetic Proteins; Cells, Cultured; Collagen Type I; Fibroblasts; Gene Expression Regulation; Glycoproteins; Heart; Intercellular Signaling Peptides and Proteins; Metalloendopeptidases; Procollagen; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta | 2003 |
Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
Topics: Aldosterone; Animals; Antigens, Neoplasm; Blood Pressure; DNA-Binding Proteins; Fibrosis; Integrins; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Knockout; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Smad2 Protein; Systole; Thrombospondin 1; Tissue Distribution; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction | 2003 |
Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats.
Topics: Actins; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Desmin; Enzyme Inhibitors; Glomerular Mesangium; Homozygote; Imidazoles; Kidney Diseases; Male; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tyrphostins | 2003 |
Effect of aldosterone on renal transforming growth factor-beta.
Topics: Aldosterone; Angiotensin I; Animals; Blood Pressure; Body Weight; Drug Implants; Gene Expression Regulation; Kidney; Male; Nuclease Protection Assays; Rats; Rats, Sprague-Dawley; Renin; Stimulation, Chemical; Transforming Growth Factor beta; Water-Electrolyte Balance | 2004 |
Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart.
Topics: Aldosterone; Angiotensin II; Animals; Chemokine CCL2; Deferoxamine; Enzyme Inhibitors; Ferritins; Fibrosis; Free Radical Scavengers; Gene Expression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Iron; Iron Chelating Agents; Male; Myocardium; Oxidative Stress; Phenylurea Compounds; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation; Vasoconstrictor Agents | 2005 |
12-Lipoxygenase metabolism in mouse distal convoluted tubule cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Aldosterone; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Base Sequence; Blood Platelets; Cell Line; DNA; Gene Expression Regulation, Enzymologic; Humans; Kidney Tubules, Distal; Leukocytes; Mice; RNA, Messenger; Transforming Growth Factor beta | 2005 |
Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes.
Topics: Aldosterone; Animals; Cell Line; Gene Expression Regulation; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Plasminogen Activator Inhibitor 1; Rats; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Biopsy; Blood Pressure; Chemokine CCL2; Female; Glomerular Basement Membrane; Humans; Immediate-Early Proteins; Interleukin-6; Ischemia; Kidney; Kidney Function Tests; Male; Middle Aged; Protein Serine-Threonine Kinases; Proteinuria; Receptors, Mineralocorticoid; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
[The effect of tubular epithelial cells activated by aldosterone on renal interstitial fibroblasts in co-culture system].
Topics: Aldosterone; Coculture Techniques; Collagen Type I; Endothelin-1; Epithelial Cells; Fibroblasts; Humans; Kidney Tubules, Proximal; Transforming Growth Factor beta | 2005 |
Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinas
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemokine CCL2; Coronary Vessels; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibrillar Collagens; Gene Expression; Heart Ventricles; Hypertension; Imidazolidines; Intracellular Signaling Peptides and Proteins; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Peptidyl-Dipeptidase A; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Scavenger Receptors, Class E; Signal Transduction; Sodium Chloride; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatine; Hypertension; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 2006 |
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Topics: Actins; Aldosterone; Animals; Blotting, Western; Cytochrome P-450 CYP11B2; Drug Therapy, Combination; Eplerenone; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Immunohistochemistry; Male; Mineralocorticoid Receptor Antagonists; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Proliferating Cell Nuclear Antigen; Protein Precursors; Random Allocation; Rats; Rats, Inbred WKY; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aldosterone; Animals; Enzyme Activation; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Time Factors; Transforming Growth Factor beta | 2006 |
Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Cells, Cultured; Cytochrome P-450 CYP11B2; Extracellular Matrix; Fibronectins; Male; Mesangial Cells; Rats; Receptors, Mineralocorticoid; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cell Proliferation; Disease Models, Animal; Diuretics; Fibrosis; Glomerulonephritis, Membranoproliferative; Ki-67 Antigen; Kidney; Mineralocorticoid Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan | 2006 |
Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone.
Topics: Aldosterone; Amyloid beta-Protein Precursor; Animals; Biological Transport; Cell Line; Electrophysiology; Epithelial Sodium Channels; Female; Gene Expression Regulation; Gene Silencing; Kidney Tubules, Collecting; Mice; Oocytes; Protease Nexins; Receptors, Cell Surface; RNA, Messenger; Serine Endopeptidases; Sodium; Sodium Channels; Transforming Growth Factor beta; Transforming Growth Factor beta1; Xenopus | 2006 |
Mineralocorticoid receptor activation promotes vascular cell calcification.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adrenal Cortex Hormones; Aldosterone; Alkaline Phosphatase; Animals; Aorta; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcinosis; Cattle; Cells, Cultured; Coronary Vessels; Humans; Minerals; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, Mineralocorticoid; Signal Transduction; Transforming Growth Factor beta; Vascular Diseases | 2007 |
Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
Topics: Aldosterone; Animals; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein 7; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Proteins; Cell Line; Cell Proliferation; Enzyme Activation; Eplerenone; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; Mesangial Cells; Mice; Mineralocorticoid Receptor Antagonists; Mitogen-Activated Protein Kinases; Mitosis; Phosphorylation; Signal Transduction; Smad6 Protein; Spironolactone; Transforming Growth Factor beta | 2007 |
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Drug Synergism; Eplerenone; Hypertension; Indoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Spironolactone; Superoxide Dismutase; Transforming Growth Factor beta | 2007 |
Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Kidney; Kidney Diseases; Male; Nephritis; NF-kappa B; Potassium; Potassium, Dietary; Rats; Rats, Sprague-Dawley; Smad7 Protein; Sodium; Transforming Growth Factor beta | 2007 |
Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats.
Topics: Adrenalectomy; Albuminuria; Aldosterone; Animals; Blood Glucose; Collagen Type IV; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Inflammation; Interleukin-6; Kidney; NF-kappa B; Rats; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2008 |
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Fibrosis; Immunohistochemistry; Kidney; Kidney Diseases; Male; Osteopontin; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad2 Protein; Smad7 Protein; Transforming Growth Factor beta | 2008 |
Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Interleukin-10; Male; Middle Aged; Renin; Renin-Angiotensin System; Spironolactone; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2009 |
Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Female; Gene Expression; Heme Oxygenase-1; Humans; Hyperaldosteronism; NADPH Oxidases; Oxidative Stress; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Transforming Growth Factor beta | 2010 |
Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats.
Topics: Aldosterone; Animals; Azetidinecarboxylic Acid; Blood Pressure; Body Weight; Calcium Channel Blockers; Collagen Type IV; Connective Tissue Growth Factor; Creatinine; Dihydropyridines; Ethidium; Gene Expression; Kidney; Kidney Diseases; Male; Mesangial Cells; NADPH Oxidases; Organ Size; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta | 2009 |
Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.
Topics: Administration, Oral; Aldosterone; Animals; Cardiomegaly; Collagen Type I; Cytochrome P-450 CYP1A1; Disease Models, Animal; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hyperaldosteronism; Hypertension; Indoles; Intercellular Adhesion Molecule-1; Magnetic Resonance Imaging; Membrane Glycoproteins; Mice; Myocardium; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Promoter Regions, Genetic; Rats; Rats, Inbred F344; Rats, Transgenic; Renin; RNA, Messenger; Time Factors; Transforming Growth Factor beta | 2009 |
Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Body Weight; Cell Size; Contraindications; Diet, Sodium-Restricted; Endomyocardial Fibrosis; Heart; Heart Failure; Hemodynamics; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Transforming Growth Factor beta; Tyrosine; Ventricular Remodeling | 2009 |
Circulating biomarkers of collagen metabolism in cardiac diseases.
Topics: Aldosterone; Biomarkers; Carrier Proteins; Collagen; Connective Tissue Growth Factor; Heart Diseases; Heart Failure; Humans; Matrix Metalloproteinase 1; Myocardium; Myocytes, Cardiac; Peptide Fragments; Procollagen; Stroke Volume; Transforming Growth Factor beta | 2010 |
Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Disease Models, Animal; Drinking; Eating; Echocardiography; Fibrosis; Gene Expression; Heart Ventricles; Hydralazine; Hypertension; Losartan; Male; Myocardium; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Transforming Growth Factor beta; Urine | 2010 |
Amlodipine suppressed cardiac gene expression of brain natriuretic peptide, transforming growth factor-β₁ and fibronectin mediated by aldosterone in male stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Fibronectins; Gene Expression Regulation; Heart; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Transforming Growth Factor beta | 2010 |
Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells.
Topics: Aldosterone; Animals; Blood Pressure; Collagen; Extracellular Matrix; Fibronectins; Fibrosis; Kidney; Mice; Mice, Transgenic; Myocardium; Organ Size; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta | 2011 |
Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Angiotensin II; Apoptosis; Cells, Cultured; Cytochrome P-450 CYP11B2; Epithelial Cells; Female; Gene Expression Regulation; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Tubules, Proximal; Male; Mesangial Cells; Oxidative Stress; Receptor, Angiotensin, Type 2; Receptors, Mineralocorticoid; Renin-Angiotensin System; Time Factors; Transforming Growth Factor beta; Up-Regulation | 2011 |
AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition.
Topics: Albumins; Aldosterone; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Cell Line; Epithelial-Mesenchymal Transition; Glucose; Heme Oxygenase-1; Humans; Metformin; NADPH Oxidase 4; NADPH Oxidases; Nephrosclerosis; Pyrazoles; Pyrimidines; Reactive Oxygen Species; Ribonucleosides; Thioredoxins; Transforming Growth Factor beta | 2013 |
Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model.
Topics: Aldosterone; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Disease Progression; Dogs; Female; Fibrosis; Heart Failure; Heart Ventricles; Kidney; Male; Natriuretic Peptide, Brain; Sympathectomy; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2014 |
Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes.
Topics: Aldosterone; Animals; Blood Pressure; Blotting, Western; Cyclic N-Oxides; Histocytochemistry; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; NF-E2-Related Factor 2; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA; Spin Labels; Spironolactone; Statistics, Nonparametric; Transforming Growth Factor beta | 2014 |
DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion.
Topics: Adrenocortical Carcinoma; Aldosterone; Disease Progression; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Real-Time Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Transcription Factors; Transforming Growth Factor beta; Tumor Cells, Cultured; Zona Glomerulosa | 2015 |
Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR.
Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Apoptosis; Cell Differentiation; Cell Line; Disease Models, Animal; ELAV-Like Protein 1; Fibrosis; Green Fluorescent Proteins; Humans; Immunophenotyping; Interleukin-10; Kidney; Kidney Tubules; Male; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Ureteral Obstruction | 2016 |
Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Blood Pressure; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Echocardiography; Female; Fibrosis; Humans; Inflammation; Interleukin-6; Male; Matrix Metalloproteinase 2; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteopontin; P-Selectin; Parathyroid Hormone; Peritoneal Dialysis; Pulse Wave Analysis; Renal Insufficiency, Chronic; Spironolactone; Thrombosis; Transforming Growth Factor beta; Vascular Stiffness | 2017 |
Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma.
Topics: ACTH-Secreting Pituitary Adenoma; Aldosterone; Animals; Antihypertensive Agents; Aorta; Cell Proliferation; Collagen; Disease Models, Animal; Eplerenone; Hydralazine; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Proto-Oncogene Proteins c-mdm2; Random Allocation; Rats, Sprague-Dawley; Spironolactone; Transforming Growth Factor beta; Vascular Remodeling; Vasodilator Agents | 2018 |
The Impact of Spironolactone on Markers of Myocardial Oxidative Status, Inflammation and Remodeling in Hyperthyroid Rats.
Topics: Aldosterone; Animals; Antioxidants; Biomarkers; Blood Pressure; Body Weight; Cardiovascular Diseases; Endothelin-1; Heart; Heart Rate; Hyperthyroidism; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Nitrites; Organ Size; Oxidative Stress; Random Allocation; Rats; Spironolactone; Thyroid Hormones; Thyroxine; Transforming Growth Factor beta | 2020 |
Altered Tregs Differentiation and Impaired Autophagy Correlate to Atherosclerotic Disease.
Topics: Aldosterone; Animals; Apolipoproteins E; Atherosclerosis; Autophagy; Cell Differentiation; Cell Polarity; Disease Models, Animal; Forkhead Transcription Factors; Humans; Male; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2020 |